Cyprus - Re-Export of Heparin for Therapeutic Use
At $10,187.59 in 2018, the country was ranked number 8 comparing other countries in Re-Export of Heparin for Therapeutic Use. Cyprus is overtaken by United Arab Emirates, which was number 7 with $46,048.8 and is followed by Moldova with $2,072. United States topped the ranking with $4,598,060.57 in 2019, -5.2% versus 2018. Canada, Barbados and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. New Zealand witnessed the best average annual growth at +141.8% per year, while United States was the worst growing country at -29.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2018 | 10,187.59 |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 |
Download all data from 2004 to 2018
How does Cyprus rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data | |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data | |
| 7 |
#7
United Arab Emirates
|
46,048.80 | 2019 | -14.7 % | +23.1 % | View data | |
| 8 |
#8
Cyprus
|
10,187.59 | 2018 | NA | NA | View data | |
| 9 |
#9
Moldova
|
2,072.00 | 2017 | +67.6 % | NA | View data | |